Episodes

  • Epi 20 -Post‑Thrombotic Syndrome

    Epi 20 -Post‑Thrombotic Syndrome
    May 19 2026
    PTS is a chronic consequence of DVT, happening despite appropriate acute management. It affects 20% to 50% of patients within 2 years of DVT diagnosis, with severe forms in 5–10%. The condition usually involves the same limb affected by the original thrombosis, and symptoms may emerge shortly after the acute event or be delayed by months or even years.

    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    5 mins
  • Epi 19 - Intracardiac Thrombosis

    Epi 19 - Intracardiac Thrombosis
    Apr 16 2026
    Intracardiac thrombi form within the atria or ventricles of the heart and pose a substantial threat due to their potential to obstruct blood flow or embolize to distant organs. While less prevalent than venous thromboembolism, ICT remains a high‑risk cardiovascular emergency, with mortality rates that may reach or exceed 30–80%, depending on the patient’s clinical status and the location of the thrombus.

    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    4 mins
  • Epi 18 - The Challenges of Post‑Op VTE

    Epi 18 - The Challenges of Post‑Op VTE
    Mar 12 2026
    Surgical procedures create a uniquely pro‑thrombotic environment. Virchow’s triad—venous stasis, endothelial injury, and hypercoagulability—describes the foundation of thrombus formation, and all three elements are markedly amplified during and after surgery. Together, these factors significantly raise the risk of developing deep vein thrombosis (DVT), which can progress into life‑threatening pulmonary embolism (PE).

    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    5 mins
  • Epi 17 - Thrombosis in Myeloproliferative Neoplasms

    Epi 17 - Thrombosis in Myeloproliferative Neoplasms
    Feb 17 2026
    The classic Philadelphia-negative MPNs, which include Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF), are myeloproliferative disorders all characterized by clonal expansion of an abnormal hematopoietic stem/progenitor cell. This leads to excessive production of mature myeloid elements, such as an overabundance of red blood cells in PV or a marked increase in platelets in ET. Although biologically distinct, these disorders share a common predisposition to thrombosis

    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    5 mins
  • Epi 16 - Disseminated Intravascular Coagulation

    Epi 16 - Disseminated Intravascular Coagulation
    Jan 15 2026
    Disseminated Intravascular Coagulation is a life-threatening intravascular disorder characterized by endothelial injury, systemic activation of coagulation, and dysregulated fibrinolysis, leading to microvascular thrombosis and consumption of platelets and clotting factors.
    Importantly, Disseminated Intravascular Coagulation is not a primary disease but a complication of underlying conditions such as sepsis, trauma, malignancy, obstetric emergencies, or severe immune reactions.


    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    5 mins
  • Epi 15 - Cold-Induced Vascular Challenges

    Epi 15 - Cold-Induced Vascular Challenges
    Jan 9 2026
    Thrombosis, Cardiovascular Risks, and Raynaud’s Phenomenon
    This episode centers on cold-induced vasoconstriction, a natural response where blood vessels constrict to preserve body heat. While this mechanism is protective, it can significantly raise the risk of thrombosis and vascular disorders, especially in individuals with pre-existing conditions.

    Winter is a critical period for vascular health. In fact, low temperatures trigger vasoconstriction, which, combined with increased platelet adhesion and reduced physical activity, heightens clot risk. The most strongly impacted pathology by cold-induced vasoconstriction is vascular disease. This deterioration occurs because constricted vessels raise blood pressure, slow circulation, limit tissue perfusion, and increase the likelihood of clot formation.

    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    4 mins
  • Epi 14 - Splanchnic Venous Thrombosis

    Epi 14 - Splanchnic Venous Thrombosis
    Jan 7 2026
    In this episode, we highlight Splanchnic Venous Thrombosis, a rare but significant subset of venous thromboembolism characterized by clot formation in the veins draining abdominal organs.
    Splanchnic Venous Thrombosis represents a heterogeneous group of disorders affecting the portal, mesenteric, splenic, and hepatic veins. While commonly linked to liver cirrhosis and malignancy, Splanchnic Venous Thrombosis can also occur in non-cirrhotic, non-neoplastic patients. Its clinical relevance stems from complications such as intestinal ischemia, portal hypertension, and potential underlying systemic disorders, including malignancies, nephrotic syndrome, thrombophilia, or inflammatory diseases.


    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    4 mins
  • Epi 13 - Travel Tips and Thrombosis

    Epi 13 - Travel Tips and Thrombosis
    Jan 5 2026
    Although the likelihood of developing thrombosis on flights exceeding four hours is relatively low—about 1 in 6,000—certain factors such as age, obesity, or recent surgery can increase susceptibility. Fortunately, these 10 practical tips can help minimize the risk while traveling.
    Listen for more information

    Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
    This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
    We hope you join this effort!

    This episode includes AI-generated content.
    Show More Show Less
    4 mins